Education
About Us
Working with TipRanks
Follow Us
China NT Pharma Group Co., Ltd. (HK:1011)
:1011
RESEARCH TOOLSreports
1011 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.19 - HK$1.40
Previous CloseN/A
Volume22.00K
Average Volume (3M)342.62K
Market Cap
HK$310.15M
Enterprise ValueHK$615.91M
Total Cash (Recent Filing)HK$9.62M
Total Debt (Recent Filing)¥375.95M
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Aug 27, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 10, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)-0.22
Shares Outstanding674,246,030
10 Day Avg. Volume275,870
30 Day Avg. Volume342,616
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.24
Price to Sales (P/S)0.00
P/FCF Ratio-42.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China NT Pharma Group Co., Ltd. News
PremiumCompany Announcements
China NT Pharma Delays Circular Dispatch for Acquisition
PremiumCompany Announcements
China NT Pharma Group Successfully Concludes AGM with All Resolutions PassedPremiumCompany Announcements
China NT Pharma Group Announces Board Composition and Committee RolesPremiumCompany Announcements
China NT Pharma Group Announces Board Committee Changes
PremiumCompany Announcements
China NT Pharma Group Updates Nomination Committee Terms
PremiumCompany Announcements
China NT Pharma Announces Leadership Change with New CEO AppointmentPremiumCompany Announcements
China NT Pharma Group Announces Potential Acquisition and Disposal Plans
PremiumCompany Announcements
China NT Pharma Achieves Profit Guarantee Milestone with Associate1011 FAQ
What was China NT Pharma Group Co., Ltd.’s price range in the past 12 months?
China NT Pharma Group Co., Ltd. lowest stock price was HK$0.19 and its highest was HK$1.40 in the past 12 months.
What is China NT Pharma Group Co., Ltd.’s market cap?
China NT Pharma Group Co., Ltd.’s market cap is HK$310.15M.
When is China NT Pharma Group Co., Ltd.’s upcoming earnings report date?
China NT Pharma Group Co., Ltd.’s upcoming earnings report date is Aug 27, 2025 which is in 53 days.
How were China NT Pharma Group Co., Ltd.’s earnings last quarter?
China NT Pharma Group Co., Ltd. released its earnings results on Mar 31, 2025. The company reported -HK$0.219 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.219.
Is China NT Pharma Group Co., Ltd. overvalued?
According to Wall Street analysts China NT Pharma Group Co., Ltd.’s price is currently Overvalued.
Does China NT Pharma Group Co., Ltd. pay dividends?
China NT Pharma Group Co., Ltd. pays a Annually dividend of HK$0.035 which represents an annual dividend yield of N/A. See more information on China NT Pharma Group Co., Ltd. dividends here
What is China NT Pharma Group Co., Ltd.’s EPS estimate?
China NT Pharma Group Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China NT Pharma Group Co., Ltd. have?
China NT Pharma Group Co., Ltd. has 674,246,030 shares outstanding.
What happened to China NT Pharma Group Co., Ltd.’s price movement after its last earnings report?
China NT Pharma Group Co., Ltd. reported an EPS of -HK$0.219 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China NT Pharma Group Co., Ltd.?
Currently, no hedge funds are holding shares in HK:1011
China NT Pharma Group Co., Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
35.29%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-68.03%
Trailing 12-Months
Company Description
China NT Pharma Group Co., Ltd.
China NT Pharma Group Co., Ltd. (1011) is a pharmaceutical company that operates in the healthcare sector, primarily focusing on the research, development, manufacturing, and distribution of pharmaceuticals. The company offers a range of products including vaccines, prescription drugs, and over-the-counter medicines, serving various therapeutic areas. It aims to provide innovative healthcare solutions in China and international markets.
Technical Analysis
Huakang Biomedical Holdings Company Limited
―
Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H
―
Fusen Pharmaceutical Co., Ltd.
―
Wai Yuen Tong Medicine Holdings Limited
―